Stem Cell Treatments Reaching Patients

Dr. Jacques Galipeau, faculty member in Immunology and Molecular Pathogenesis, discusses stem cell treatments in a San Diego Union-Tribune article. After many years of waiting, a flood of new regenerative-cell therapies is finally reaching patients. Worldwide, 226 trials are being conducted with stem cells, including 45 in the U.S. These cells function as “natural immune regulators,” said Dr. Galipeau, who is leading a study on using these cells to treat Crohn’s disease, an inflammatory autoimmune disorder of the bowels. Click here to view the full San Diego Union-Tribune article.